McGowan Group Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
McGowan Group Asset Management's PFE Position: Q4 2024 in Review
McGowan Group Asset Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,553 shares — an estimated $248K sold.
McGowan Group Asset Management first reported a position in PFE in Q3 2018 and held it in 15 quarters. The position peaked at $584K in Q2 2020. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- McGowan Group Asset Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- McGowan Group Asset Management sold 8,553 Pfizer shares in Q4 2024, an estimated $248K.
- McGowan Group Asset Management first reported a position in Pfizer in Q3 2018 and held it in 15 quarters.
- McGowan Group Asset Management's Pfizer position peaked at $584K in Q2 2020.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on McGowan Group Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.